Drug Type Cell therapy |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Inactive Indication- |
Originator Organization Eyestem Research Pvt Ltd.Startup |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
dry age-related macular degeneration | Phase 2 | IN | Eyestem Research Pvt Ltd.Startup | 04 Jun 2024 |
Geographic Atrophy | Phase 2 | IN | Eyestem Research Pvt Ltd.Startup | 04 Jun 2024 |
Dystrophy, Macular | Preclinical | US | Eyestem Research Pvt Ltd.Startup | - |
Dystrophy, Macular | Preclinical | IN | Eyestem Research Pvt Ltd.Startup | - |
Dystrophy, Macular | Preclinical | IN | - | |
Dystrophy, Macular | Preclinical | US | - |